As of 2025-07-14, the EV/EBITDA ratio of AnaptysBio Inc (ANAB) is -4.20. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AnaptysBio's latest enterprise value is 671.12 mil USD. AnaptysBio's TTM EBITDA according to its financial statements is -159.61 mil USD. Dividing these 2 quantities gives us the above AnaptysBio EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 9.7x | 8.4x |
| Forward P/E multiples | 11.3x - 13.9x | 12.0x |
| Fair Price | (58.25) - (49.34) | (52.19) |
| Upside | -322.3% - -288.3% | -299.2% |
| Date | EV/EBITDA |
| 2025-07-11 | -4.20 |
| 2025-07-10 | -4.18 |
| 2025-07-09 | -4.12 |
| 2025-07-08 | -3.85 |
| 2025-07-07 | -3.70 |
| 2025-07-03 | -3.75 |
| 2025-07-02 | -3.78 |
| 2025-07-01 | -3.55 |
| 2025-06-30 | -3.47 |
| 2025-06-27 | -3.52 |
| 2025-06-26 | -3.69 |
| 2025-06-25 | -3.66 |
| 2025-06-24 | -3.67 |
| 2025-06-23 | -3.58 |
| 2025-06-20 | -3.65 |
| 2025-06-18 | -3.69 |
| 2025-06-17 | -3.77 |
| 2025-06-16 | -3.78 |
| 2025-06-13 | -3.67 |
| 2025-06-12 | -3.69 |
| 2025-06-11 | -3.73 |
| 2025-06-10 | -3.79 |
| 2025-06-09 | -3.65 |
| 2025-06-06 | -3.74 |
| 2025-06-05 | -3.27 |
| 2025-06-04 | -3.30 |
| 2025-06-03 | -3.71 |
| 2025-06-02 | -3.41 |
| 2025-05-30 | -3.47 |
| 2025-05-29 | -3.53 |
| 2025-05-28 | -3.23 |
| 2025-05-27 | -3.09 |
| 2025-05-23 | -3.14 |
| 2025-05-22 | -3.20 |
| 2025-05-21 | -3.21 |
| 2025-05-20 | -3.27 |
| 2025-05-19 | -3.15 |
| 2025-05-16 | -3.10 |
| 2025-05-15 | -3.14 |
| 2025-05-14 | -2.96 |
| 2025-05-13 | -3.16 |
| 2025-05-12 | -3.07 |
| 2025-05-09 | -2.99 |
| 2025-05-08 | -2.99 |
| 2025-05-07 | -3.00 |
| 2025-05-06 | -3.09 |
| 2025-05-05 | -3.20 |
| 2025-05-02 | -3.28 |
| 2025-05-01 | -3.38 |
| 2025-04-30 | -3.47 |